Be The First To
In the war against cancer, CuraGen is looking for the ultimate weapon. The drug company's main focus is on developing an antibody therapy to treat metastatic melanoma and breast cancer. The anticancer compound (called CR011) is a monoclonal antibody that is combined with a cell-killing drug using technology from Seattle Genetics. In addition to CR011, CuraGen has a portfolio of early-stage compounds in the areas of oncology and inflammatory disease, including a preclinical candidate for ovarian cancer and renal cell carcinoma. In 2009 CuraGen was acquired by fellow biotech...
This is the employer's chance to tell you why you should work for them. The information provided is from their perspective.
Employees are “Satisfied” 1 ratings
Not yet rated.
Anthony S. Marucci
Founder, President, Chief Executive Officer and Director
|Salaries in USD||Avg. Salary|| |
1 CuraGen Salary
= Salary Range
= Anonymous Salary Range
Let us know if we're missing any workplace or industry recognition –